Lipocine Inc.
LPCN | NASDAQ
$2.14
-$0.10 (-4.46%)
Sep 22, 2026, 12:26 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.54 | 3.05K | -0.89 | -3.15 | -88.68 | -3.58 |
PEG Ratio | 0 | -30.48 | -0.02 | 0 | 0.91 | 0.15 |
PS Ratio | 22.14 | 2.33 | -5.16 | 67.61 | 3.45 | n/a |
PB Ratio | 3.02 | 1.24 | 0.72 | 0.95 | 1.22 | 4.89 |
P/FCF Ratio | -4.48 | -19.87 | -1.24 | -2.79 | -12.59 | -4.90 |
P/OCF Ratio | -4.48 | -21.33 | -1.24 | -2.82 | -12.61 | -4.90 |
OCF/S Ratio | -493.79 | -10.91 | 416.23 | -2.39K | -27.33 | n/a |
Debt / Equity Ratio | 0.03 | n/a | n/a | n/a | 0.05 | 0.36 |
Quick Ratio | 6.68 | 14.75 | 8.69 | 20.34 | 8.26 | 3.85 |
Current Ratio | 6.68 | 14.75 | 8.69 | 20.34 | 8.26 | 3.85 |
Asset Turnover | 0.12 | 0.50 | -0.12 | 0.01 | 0.31 | n/a |
Interest Coverage | n/a | n/a | n/a | -447.24 | 15.47 | -46.55 |
Return on Equity | -66.50% | 0.04% | -80.28% | -30.19% | -1.39% | -136.65% |
Return on Assets | -56.61% | 0.04% | -71.09% | -28.66% | -1.21% | -82.69% |
Return on Invested Capital | -69.48% | -5.09% | -88.03% | -33.79% | 6.40% | -81.42% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -334.26% | 100% | 456.92% | -1.61K% | 52.51% | n/a |
Net Profit Margin | -487.06% | 0.07% | 573.59% | -2.15K% | -3.93% | n/a |
Pretax Profit Margin | -487.04% | 0.08% | 573.57% | -2.15K% | -3.93% | n/a |
Operating Profit Margin | -524.69% | -10.31% | 628.98% | -2.42K% | 19.49% | n/a |
FCF Margin | -493.79% | -11.71% | 416.69% | -2.42K% | -27.38% | n/a |
EBITDA Margin | -483.97% | 0.45% | 572.56% | -2.14K% | -2.67% | n/a |
Add to Watchlist
Select watchlists to add or remove LPCN